Niowave, Inc. and Ratio Therapeutics Sign Supply Agreement for Actinium-225 to Advance Targeted Alpha Therapies
June 16, 2026
LANSING, MI and BOSTON, MA, June 16, 2026— Niowave, Inc., a leading manufacturer of medical...
Read More about Niowave, Inc. and Ratio Therapeutics Sign Supply Agreement for Actinium-225 to Advance Targeted Alpha Therapies
